Recruiting studies: Organ Donor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169 Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377 Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignan
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06734091 ICU Management of Brain-Dead Donors Before Multi-Organ Procurement and Factors Associated With the Number of Organs Retr
Phase N/A · 2 location(s) · Société Française d'Anesthésie et de Réanimation · NCT06768515 CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Hong Kong Children's Hospital · NCT06034535 Endothelial Glycocalyx Damage in Brain Death Organ Donors
Phase N/A · 1 location(s) · University Hospital Hradec Kralove · NCT05609123 Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675 Study of the Brain's Natural Cleaning System in Potential Organ Donors.
NA · 1 location(s) · Germans Trias i Pujol Hospital · NCT07682155 Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive
Phase N/A · 1 location(s) · Tulane University · NCT05159466 University of Minnesota Transplant Registry
Phase N/A · 1 location(s) · University of Minnesota · NCT01062581 Uterus Transplantation From a Multi-organ Donor
NA · 1 location(s) · University Hospital, Ghent · NCT03252795 Anesthesia sTrategy foR Organ Procurement In braiN dEath
Phase 3 · 1 location(s) · University Hospital, Grenoble · NCT07166991 Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
NA · 1 location(s) · Massachusetts General Hospital · NCT06088758 Multimodal Neuromonitoring During Normothermic Regional Perfusion for Organ Donors Determined Dead by circuLatory Criter
Phase N/A · 1 location(s) · University of British Columbia · NCT07423936 ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biop
Phase N/A · 1 location(s) · Medical University of Vienna · NCT06982404 CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053488 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiati
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06287944 TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05384756 Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
NA · 6 location(s) · Johns Hopkins University · NCT03803423 Impact of Perioperative Organ Resuscitation of Brain-dead Deceased Organ Donor on Kidney Graft Function in the Recipient
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06907758 Long-term Outcomes After Prolonged Dual Hypothermic Oxygenated Machine Perfusion of Donor Livers (DHOPEPROLONG)
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT05680246

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.